| Also known as |
Cefspan, Cephoral |
| Blood pressure |
No direct effect |
| Chemical name |
(6R,7R)-7-{[2-(2-Amino-1,3-thiazol-4-yl)-2-carboxypropan-2-yloxyimino]acetyl}amino-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
| Dosage (medical) |
400 mg daily or divided into two doses of 200 mg each |
| Dosage (sports) |
Not applicable |
| Effects |
Effective against a wide range of gram-positive and gram-negative bacteria |
| Formula |
C16H15N5O7S2 |
| Half-life |
3 to 4 hours |
| Hepatotoxicity |
Rare, mild transient elevations in liver enzymes |
| Lab Test |
May interfere with certain types of diagnostic tests, including urine glucose tests using Benedict's solution or Fehling's solution |
| Main action |
Bactericidal (inhibits bacterial cell wall synthesis) |
| Side effects |
Diarrhea, nausea, abdominal pain, dizziness, headache, allergic reactions |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Strength |
200 mg |
| Substance class |
Third-generation cephalosporin antibiotic |
| Trade name |
Suprax, among others |
| Use in sports |
Not typically used in sports |
| Water Retention |
None |
| Manufacturer |
Zuventus Healthcare Ltd. |
